LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,193 Cr | ₹1,159 Cr | ₹1,179 Cr | ₹928 Cr | ₹693 Cr |
What is the latest Total Non-Current Liabilities ratio of LAURUS LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1,193 Cr |
| Mar2024 | ₹1,159 Cr |
| Mar2023 | ₹1,179 Cr |
| Mar2022 | ₹928 Cr |
| Mar2021 | ₹693 Cr |
How is Total Non-Current Liabilities of LAURUS LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,193 Cr | 2.95 | |
| Mar2024 | ₹1,159 Cr | -1.72 | |
| Mar2023 | ₹1,179 Cr | 27.10 | |
| Mar2022 | ₹928 Cr | 33.94 | |
| Mar2021 | ₹693 Cr | - | |
Compare Total Non-Current Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹74,679.0 Cr | 0.7% | 25.9% | 130.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,469.0 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,305.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,014.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,388.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,381.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 0.7% |
25.9% |
130.7% |
| SENSEX | -2.4% |
-3.7% |
-9.2% |
You may also like the below Video Courses